Brief: Bergenbio Q2 Operating Loss NOK 88.2 Mln

Oncoinvent ASA

23/08/2022 06:05

Aug 23 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * REVENUE AMOUNTED TO NOK 0.0 MILLION (NOK 0.0 MILLION) FOR
Q2
2022
    * TOTAL OPERATING EXPENSES FOR Q2 WERE NOK 88.2 MILLION (NOK
92.3
MILLION)
    * OPERATING LOSS FOR Q2 CAME TO NOK 88.2 MILLION (NOK 92.3
MILLION)

Source text for Eikon:  ID:nWkrbNGGF0 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))